FMO5 and neoplasm: Lmo@RBC generated immunogenicity through activating CD8+ and CD4+ T cells and eliminated tumor cells via producing NADPH oxidase-mediated reactive oxygen species (ROS) while retaining the capability of living Lmo to colonize the anaerobic tumor microenvironment.